Rationale: The withdrawal of humans from high doses of psychostimulant drugs can result in a transient syndrome which appears isomorphic to endogenous depression. One of the more prominent symptoms is a loss of hedonic capacity; in animals, the anhedonia associated with amphetamine withdrawal has been measured objectively by decrements in responding for intracranial self-stimulation (ICSS).
Objective: To date, the effects of amphetamine withdrawal on ICSS responding have been reversed by different antidepressant drugs. In the present study, we sought to reverse withdrawal-induced anhedonia by administration of repeated electroconvulsive shocks (ECS).
Methods: Rats with electrodes in the lateral hypothalamus were trained on an ascending-series current intensity ICSS paradigm until stable levels of responding were attained. Half of the animals were then administered a 4-day escalating dose schedule of d-amphetamine, and tests for ICSS responding started 12 h after the final injection. During withdrawal, all animals received daily treatment with either ECS or sham-ECS.
Results: Amphetamine withdrawal was associated with reduced ICSS responding; animals treated with ECS exhibited a facilitated recovery compared to sham-ECS treated animals, and returned to control levels of ICSS responding 24 h earlier.
Conclusions: ECS was able to mitigate the anhedonic effects of d-amphetamine withdrawal, and provides additional support for the use of psychostimulant withdrawal as a model of depression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s002130100906 | DOI Listing |
BMC Public Health
December 2024
Department of Chemical Engineering, Gafat Institute of Technology, Debre Tabor University, Debre, Tabor, Ethiopia.
This study examined the influence of socio-economic factors on the adoption of improved cookstoves (ICSs) and identified barriers to their dissemination in Wereta district, Amhara, Ethiopia. A structured cross-sectional approach was employed, surveying 308 households through questionnaires and interviews. Key socio-economic factors such as income level, family size, education, and age were found to significantly affect ICS adoption (p < 0.
View Article and Find Full Text PDFBMJ Open Respir Res
October 2024
Health Economics Unit, Stoke on Trent, UK.
Introduction: Treatment options for chronic obstructive pulmonary disease (COPD) are numerous but adherence remains a key challenge. We performed a discrete choice experiment (DCE) of patients' preferences in accessing care for the management of COPD. The aim of this study was to understand patients' preferences for modes of accessing care for the management of COPD.
View Article and Find Full Text PDFFront Mol Neurosci
September 2024
Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Background: Most smokers attempting to quit will quickly relapse to tobacco use even when treated with the most efficacious smoking cessation agents currently available. This highlights the need to develop effective new smoking cessation medications. Evidence suggests that positive allosteric modulators (PAM) and other enhancers of nicotinic acetylcholine receptor (nAChR) signaling could have therapeutic utility as smoking cessation agents.
View Article and Find Full Text PDFAnal Chem
September 2024
Key Laboratory of Luminescence Analysis and Molecular Sensing (Ministry of Education), College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
Multimodal immunochromatographic sensors (ICSs) have acquired extensive attention since they not only provide reliable results by comparing the different output signals but also flexibly respond to various application environments. Herein, an ICS with triple signal outputs including colorimetry, temperature, and pressure was developed for sensitive detection of chlorothalonil. The multivalent Pt/TiCTx nanoparticles as signal tags were facilely synthesized by loading PtNPs onto single-layer TiCTx nanosheets with high surface area.
View Article and Find Full Text PDFJMIR Med Inform
April 2024
Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, United States.
Inhaled corticosteroid (ICS) is a mainstay treatment for controlling asthma and preventing exacerbations in patients with persistent asthma. Many types of ICS drugs are used, either alone or in combination with other controller medications. Despite the widespread use of ICSs, asthma control remains suboptimal in many people with asthma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!